A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...

Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

Ultra-processed food consumption in obese adolescents is linked to insulin resistance and liver disease, stressing the need ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) — previously known as "non-alcoholic fatty liver disease" — ...

Researchers at the University of Missouri found that diet and exercise can significantly improve liver disease caused by too ...

The London-based biotechnology company said the non-dilutive funding will support its ongoing development of its lead gene therapy, GF-1002, for the treatment of metabolic associated steatohepatitis, ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular disease – the leading cause of death worldwide.   University of Leeds ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular disease – the leading cause of death worldwideNew Delhi: University of ...